Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Lupin

Sector: Healthcare | Industry: Drugs & Pharma
R 726.50 -6.35  | -0.87% -18.98% 46.52 32,880.32
NSE Price: Oct 17, 15:58 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 17, 15:58 726.50 -6.35 -0.87% 731.50 732.85 744,122 719.00 - 732.00
BSE Oct 17, 2019 726.40 -5.90 -0.81% 732.00 732.30 24,072 719.35 - 732.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER

Back to Top


Chairman's Speech

As on Mar-18
Download PDF

Directors' Report

As on Mar-18
Download PDF

Corporate Governance

As on Mar-18
Download PDF

Auditors' Report

As on Mar-18
Download PDF

Notes to Accounts Statement

As on Mar-18
Download PDF
Essential checks
Altman Z-Score
3.30
Piotroski F-Score
5
Modified C-Score
1
5-Years Price to Earnings
46.52
5-Years Price to Book
2.38
Earnings Yield
EBIT / Enterprise value
5.18%
PEG
Price / Earnings to growth ratio
-2.40
Related Stocks
  Current Price   Chng %
Abbott India R10,984.05 +0.32%
Alkem Laboratories R1,918.85 +0.23%
Biocon R258.05 -0.73%
Cadila Healthcare R237.80 +1.32%
Cipla R446.30 -0.11%
Glaxosmithkline Pharma R1,440.10 +0.76%
Pfizer R3,195.65 +0.15%
Piramal Enterprises R1,468.85 +6.77%
Sanofi India R6,052.80 +1.21%
Torrent Pharmaceuticals R1,694.50 +3.19%
As on Oct 17, 15:59